Living longer with adult high-grade glioma: Setting a research agenda for patients and their caregivers

Journal of Neuro-Oncology

Volumn 120, Issue 1, 2014, Pages 1-10

  Russell, Bethany ^a   Collins, Anna ^a   Dally, Michael ^b   Dowling, Anthony ^a   Gold, Michelle ^c   Murphy, Michael ^a   Philip, Jennifer ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b EPWORTH HOSPITAL   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Caregivers; Glioma; High grade glioma; Quality of life; Survivors

Indexed keywords

ADULT; ANXIETY; CAREGIVER; CAREGIVER BURDEN; COGNITION; EXPERIENCE; FUNCTIONAL STATUS; GLIOMA; HEALTH CARE QUALITY; HUMAN; LONG TERM SURVIVAL; OUTCOME ASSESSMENT; PSYCHOMETRY; QUALITY OF LIFE; REVIEW; SOCIAL PSYCHOLOGY; ADAPTIVE BEHAVIOR; BRAIN TUMOR; CANCER GRADING; DAILY LIFE ACTIVITY; PROGNOSIS; PSYCHOLOGY; TIME;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ADULT; BRAIN NEOPLASMS; CAREGIVERS; GLIOMA; HUMANS; NEOPLASM GRADING; PROGNOSIS; QUALITY OF LIFE; TIME FACTORS;

EID: 84910147112     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1516-0     Document Type: Review

References (53)

1. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 14(Suppl 5):v1–v49. doi:10.1093/neuonc/nos218
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. doi:10.1056/NEJMoa043330
3. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507. doi:10.1056/NEJMra0708126
4. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G (2007) Long-term survival with glioblastoma multiforme. Brain 130(Pt 10):2596–2606. doi:10.1093/brain/awm204
5. Das P, Puri T, Jha P, Pathak P, Joshi N, Suri V, Sharma MC, Sharma BS, Mahapatra AK, Suri A, Sarkar C (2011) A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival. J Clin Neurosci 18(1):66–70. doi:10.1016/j.jocn.2010.04.050
6. Gupta K, Salunke P (2012) Molecular markers of glioma: an update on recent progress and perspectives. J Cancer Res Clin Oncol 138(12):1971–1981. doi:10.1007/s00432-012-1323-y
7. Hottinger AF, Yoon H, DeAngelis LM, Abrey LE (2009) Neurological outcome of long-term glioblastoma survivors. J Neurooncol 95(3):301–305. doi:10.1007/s11060-009-9946-9
8. Bahr O, Herrlinger U, Weller M, Steinbach JP (2009) Very late relapses in glioblastoma long-term survivors. J Neurol 256(10):1756–1758. doi:10.1007/s00415-009-5167-6
9. Armstrong CL, Gyato K, Awadalla AW, Lustig R, Tochner ZA (2004) A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy. Neuropsychol Rev 14(1):65–86
10. Chowdhary A, Spence AM, Sales L, Rostomily RC, Rockhill JK, Silbergeld DL (2012) Radiation associated tumors following therapeutic cranial radiation. Surg Neurol Int 3:48. doi:10.4103/2152-7806.96068
11. Efficace F, Bottomley A (2003) Assessing HRQOL: a neglected issue for high-grade glioma. Lancet Oncol 4(1):11–12
12. Colen CB, Allcut E (2012) Quality of life and outcomes in glioblastoma management. Neurosurg Clin N Am 23(3):507–513. doi:10.1016/j.nec.2012.04.010
13. Henriksson R, Asklund T, Poulsen HS (2011) Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neurooncol 104(3):639–646. doi:10.1007/s11060-011-0565-x
14. Ford E, Catt S, Chalmers A, Fallowfield L (2012) Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol 14(4):392–404. doi:10.1093/neuonc/nor229
15. Moore G, Collins A, Brand C, Gold M, Lethborg C, Murphy M, Sundararajan V, Philip J (2013) Palliative and supportive care needs of patients with high-grade glioma and their carers: a systematic review of qualitative literature. Patient Educ Couns 91(2):141–153. doi:10.1016/j.pec.2012.11.002
16. Sterckx W, Coolbrandt A, Bernatte Koen, Decruyenaere M, Borgenon S, Mees A, Clement P (2013) The impact of a high-grade glioma on everyday life: a systematic review from the patient’s and caregiver’s perspective. Eur J Oncol Nurs 17(1):107–117. doi:10.1016/j.ejon.2012.04.006
17. Sizoo EM, Dirven L, Reijneveld JC, Postma TJ, Heimans JJ, Deliens L, Pasman HR, Taphoorn MJ (2014) Measuring health-related quality of life in high-grade glioma patients at the end of life using a proxy-reported retrospective questionnaire. J Neurooncol 116(2):283–290. doi:10.1007/s11060-013-1289-x
18. Collins A, Lethborg C, Brand C, Gold M, Moore G, Sundararajan V, Murphy M, Philip J (2014) The challenges and suffering of caring for people with primary malignant glioma: qualitative perspectives on improving current supportive and palliative care practices. BMJ Support Palliat Care 4(1):68–76. doi:10.1136/bmjspcare-2012-000419
19. Feuerstein M, Hansen JA, Calvio LC, Johnson L, Ronquillo JG (2007) Work productivity in brain tumor survivors. J Occup Environ Med 49(7):803–811. doi:10.1097/JOM.0b013e318095a458
20. Halkett GK, Lobb EA, Oldham L, Nowak AK (2010) The information and support needs of patients diagnosed with high grade glioma. Patient Educ Couns 79(1):112–119. doi:10.1016/j.pec.2009.08.013
21. Janda M, Eakin EG, Bailey L, Walker D, Troy K (2006) Supportive care needs of people with brain tumours and their carers. Support Care Cancer 14(11):1094–1103
22. Janda M, Steginga S, Langbecker D, Dunn J, Walker D, Eakin E (2007) Quality of life among patients with a brain tumor and their carers. J Psychosom Res 63(6):617–623. doi:10.1016/j.jpsychores.2007.06.018
23. Janda M, Steginga S, Dunn J, Langbecker D, Walker D, Eakin E (2008) Unmet supportive care needs and interest in services among patients with a brain tumour and their carers. Patient Educ Couns 71(2):251–258. doi:10.1016/j.pec.2008.01.020
24. Keir ST, Farland MM, Lipp ES, Friedman HS (2009) Family appraisal of caregiving in a brain cancer model. J Hosp Palliat Nurs 11(1):60–66
25. Khan F, Amatya B (2013) Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour. J Neurooncol 111(3):355–366. doi:10.1007/s11060-012-1024-z
26. Kvale EA, Murthy R, Taylor R, Lee JY, Nabors LB (2009) Distress and quality of life in primary high-grade brain tumor patients. Support Care Cancer 17(7):793–799. doi:10.1007/s00520-008-0551-9
27. Lamperti E, Pantaleo G, Finocchiaro CY, Silvani A, Botturi A, Gaviani P, Sarno L, Salmaggi A (2012) Recurrent brain tumour: the impact of illness on patient’s life. Support Care Cancer 20(6):1327–1332. doi:10.1007/s00520-011-1220-y
28. Meyers CA, Hess KR, Yung WK, Levin VA (2000) Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18(3):646–650
29. Muñoz C, Juarez G, Muñoz ML, Portnow J, Fineman I, Badie B, Mamelak A, Ferrell B (2008) The quality of life of patients with malignant gliomas and their caregivers. Soc Work Health Care 47(4):455–478. doi:10.1080/00981380802232396
30. Osoba D, Brada M, Prados MD, Yung WK (2000) Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro Oncology 2(4):221–228
31. Ownsworth T, Hawkes AL, Chambers S, Walker DG, Shum D (2010) Applying a biopsychosocial perspective to investigate factors related to emotional adjustment and quality of life for individuals with brain tumour. Brain Impair 11(3):270–280. doi:10.1375/brim.11.3.270
32. Philip J, Collins A, Brand CA, Moore G, Lethborg C, Sundararajan V, Murphy MA, Gold M (2014) “I’m just waiting…”: an exploration of the experience of living and dying with primary malignant glioma. Support Care Cancer 22(2):389–397. doi:10.1007/s00520-013-1986-1
33. Salander P, Bergenheim AT, Henriksson R (2000) How was life after treatment of a malignant brain tumour? Soc Sci Med 51(4):589–598. doi:10.1016/S0277-9536(00)00002-2
34. Bosma I, Reijneveld JC, Douw L, Vos MJ, Postma TJ, Aaronson NK, Muller M, Vandertop WP, Slotman BJ, Taphoorn MJB, Heimans JJ, Klein M (2009) Health-related quality of life of long-term high-grade glioma survivors. Neuro Oncol 11(1):51–58. doi:10.1215/15228517-2008-049
35. Davies E, Hall S, Clarke C (2003) Two year survival after malignant cerebral glioma: patient and relative reports of handicap, psychiatric symptoms and rehabilitation. Disabil Rehabil 25(6):259–266
36. Flechl B, Ackerl M, Sax C, Dieckmann K, Crevenna R, Gaiger A, Widhalm G, Preusser M, Marosi C (2012) Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors. J Neurooncol 109(2):331–339. doi:10.1007/s11060-012-0897-1
37. Fox SW, Lyon D, Farace E (2007) Symptom clusters in patients with high-grade glioma. J Nurs Scholarsh 39(1):61–67
38. Giovagnoli AR, Silvani A, Colombo E, Boiardi A (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76(4):562–568
39. Keir ST, Farland MM, Lipp ES, Friedman HS (2008) Distress persists in long-term brain tumor survivors with glioblastoma multiforme. J Cancer Surviv 2(4):269–274. doi:10.1007/s11764-008-0069-7
40. Lovely MP, Stewart-Amidei C, Page M, Mogensen K, Arzbaecher J, Lupica K, Maher ME (2013) A new reality: long-term survivorship with a malignant brain tumor. Oncol Nurs Forum 40(3):267–274. doi:10.1188/13.ONF.267-274
41. Schmidinger M, Linzmayer L, Becherer A, Fazeny-Doemer B, Fakhrai N, Prayer D, Killer M, Ungersboeck K, Dieckmann K, Marosi C (2003) Psychometric- and quality-of-life assessment in long-term glioblastoma survivors. J Neurooncol 63(1):55–61
42. Steinbach JP, Blaicher HP, Herrlinger U, Wick W, Nägele T, Meyermann R, Tatagiba M, Bamberg M, Dichgans J, Karnath HO, Weller M (2006) Surviving glioblastoma for more than 5 years: the patient’s perspective. Neurology 66(2):239–242. doi:10.1212/01.wnl.0000194221.89948.a0
43. Wasner M, Paal P, Borasio GD (2013) Psychosocial care for the caregivers of primary malignant brain tumor patients. J Soc Work End Life Palliat Care 9(1):74–95. doi:10.1080/15524256.2012.758605
44. Yavas C, Zorlu F, Ozyigit G, Gurkaynak M, Yavas G, Yuce D, Cengiz M, Yildiz F, Akyol F (2012) Health-related quality of life in high-grade glioma patients: a prospective single-center study. Support Care Cancer 20(10):2315–2325. doi:10.1007/s00520-011-1340-4
45. Scott N, Fayers P, Aaronson N, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen M, Sprangers M (2008) EORTC QLQ-C30 reference values. EORTC Quality of Life Group, Belgium
46. Salander P, Bergenheim T, Henriksson R (1996) The creation of protection and hope in patients with malignant brain tumours. Soc Sci Med 42(7):985–996
47. Schwartz CE, Rapkin BD (2004) Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal. Health Qual Life Outcomes 2:16. doi:10.1186/1477-7525-2-16
48. Sneeuw KC, Aaronson NK, Osoba D, Muller MJ, Hsu MA, Yung WK, Brada M, Newlands ES (1997) The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care 35(5):490–506
49. Brown PD, Decker PA, Rummans TA, Clark MM, Frost MH, Ballman KV, Arusell RM, Buckner JC (2008) A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life. Am J Clin Oncol 31(2):163–168. doi:10.1097/COC.0b013e318149f1d3
50. Australian Government (2011) National carer strategy. Commonwealth of Australia, Canberra
51. HM Government (2010) Recognised, valued and supported: next steps for the carers strategy. Department of Health, London
52. Canadian Caregiver Coalition (2008) A framework for a Canadian caregiver strategy. Canadian Caregiver Coalition, Canada
53. Efficace F, Bottomley A (2002) Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur J Cancer 38(14):1824–1831